Comparative study of Sitagliptin versus Metformin as an Initial Monotherapy in newly diagnosed Type 2 Diabetic subjects
Azhar Memon, Kashif Rasheed Shaikh, Muhammad Atif Ata, Umair Ali Soomro, Shumaila Shaikh, Shumail Saeed Siddiqui.
Abstract
ABSTRACT
Objective: To study, analyse and compare the pharamacological efficacy of sitagliptin and metfromin in terms of blood glucose and glycated HbA1 in type 2 diaebtic (T2DM) subjects.
Methodology: An observational study was conducted at the Suleman Roshan Medical College from March 2019 to February 2020. A sample of 200 diagnosed cases of type 2 DM, divided into 100 sitaglitin and 100 metformin, was selected according to inclusion criteria. Sample was selected by non-probability convenient sampling. After 12 weeks therapy, the blood samples were taken, centrifuged and sera for biochemcial analysis. Fasting (FBG) and random blood glucose (RBG) and glycated HbA1 (HbA1c) were estimated by standard methods. Data was analyzed on SPSS (ver. 21.0) at 95% CI (P≤0.05).
Results: Age of Sitagliptin group was 50.5±11.5 comapred Metformin group 50.1±15.5 years (P=0.07). FBG in sitagliptin was decreased by 46% vs. 37% in metformin; RBG in sitagliptin was decreased by 90% vs. 69% in metformin and HbA1c decreased by 14.35 in sitagliptin vs. 11.4% in metformin. Nausea, vomiting, diarrhoea and headache was noted in 3%, 3%, 6% and 5% of those taking sitagliptin compared to 19%, 5%, 13% and 11% in metformin treated subjects respectively (P
Key words: Sitagliptin, metformin, glycemic control, type 2 diabetics.
The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
We use cookies and other tracking technologies to work properly, to analyze our website traffic, and to understand where our visitors are coming from. More InfoGot It!
